Tuesday, January 13, 2026

6:00 PM – 6:30 PM: Registration and Dinner
6:30 PM – 8:00 PM: CME Presentation

Miami Marriott Biscayne Bay
1633 North Bayshore Drive,
Miami, Florida, 33132

PROGRAM FEATURES

NEED

PRESENTING FACULTY

	Sudheer Potru, DO, FASAM Anesthesiologist/Pain Management Specialist/Addictionologist Atlanta VA Medical Center Greater Atlanta Area
	Michael D. Cheshire, DO, FACOI, FACP, FNLA Program Director, WVU School of Medicine Camden Clark Internal Medicine Program Medical Director, Camden Clark Internal Medicine Clinic Clinical Associate Professor, WVU School of Medicine Parkersburg, West Virgina
	James Q. Zhou, MD Attending Physician, Hospital Medicine Unit Attending Physician, Addiction Consult Team Massachusetts General Hospital Boston, Massachusetts

PROGRAM OVERVIEW

NEED

TARGET AUDIENCE

Consistent with the goals of the FDA REMS blueprint, this REMS-compliant continuing education program is designed to meet the educational needs of a broad range of health care professionals, nationally, including medication prescribers and care team members; physicians (including primary care, internal medicine, emergency medicine, surgery, pain medicine, addiction medicine), advanced practice nurses (eg, APRN, CNS, NP, DNP, CRNA, CNMW, other), physician assistants, dentists, podiatrists, nurses, pharmacists, optometrists, and psychologists.

LEARNING OBJECTIVES

Upon completion of this activity, attendees will have improved ability to:

1. Articulate the foundational elements of pain management, distinguishing between definitions, classifications, and mechanisms of pain.
2. Conduct comprehensive pain assessments that evaluate pain severity and identify patient-specific risk factors for nonmedical opioid use and opioid use disorder.
3. Apply effective strategies for managing acute and chronic pain that prioritize the use of nonpharmacologic and non-opioid pharmacologic modalities.
4. Develop guideline-driven strategies for initiating, titrating, and discontinuing opioid analgesics, while emphasizing individualized treatment plans, secure storage protocols, and counseling approaches for patients and caregivers concerning naloxone use during opioid overdose.
5. Recognize clinical indicators for specialist referral and facilitate timely consultations with pain management and addiction medicine.
6. Outline the core principles of addiction medicine and apply evidence-based strategies for recognizing and managing opioid use disorder.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of up to 1.5 ANCC contact hours.

ACCME INNOVATIVE PARTNER

Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.

PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]